American Well Corporation (NYSE:AMWL) Short Interest Update

American Well Corporation (NYSE:AMWL) saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 345,059 shares, an increase of 109.8% from the January 29th total of 164,468 shares. Approximately 2.4% of the company’s stock are sold short. Based on an average trading volume of 211,717 shares, the short-interest ratio is currently 1.6 days. Based on an average trading volume of 211,717 shares, the short-interest ratio is currently 1.6 days. Approximately 2.4% of the company’s stock are sold short.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of American Well in a report on Wednesday, January 21st. Morgan Stanley dropped their price target on shares of American Well from $10.50 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, December 18th. Wells Fargo & Company decreased their price target on shares of American Well from $12.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Stifel Nicolaus lowered their price target on shares of American Well from $6.00 to $5.00 and set a “hold” rating for the company in a report on Friday, February 13th. Finally, Wall Street Zen upgraded American Well from a “sell” rating to a “hold” rating in a research report on Saturday, February 14th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $7.42.

American Well Stock Down 1.8%

NYSE:AMWL traded down $0.10 on Friday, reaching $5.65. 22,959 shares of the company’s stock were exchanged, compared to its average volume of 146,653. The firm has a market capitalization of $93.49 million, a price-to-earnings ratio of -0.95 and a beta of 1.36. American Well has a 52-week low of $3.71 and a 52-week high of $10.12. The business has a fifty day moving average of $4.89 and a 200-day moving average of $5.32.

American Well (NYSE:AMWL) last issued its earnings results on Thursday, February 12th. The company reported ($1.52) earnings per share for the quarter, topping the consensus estimate of ($1.59) by $0.07. American Well had a negative return on equity of 35.33% and a negative net margin of 38.38%.The business had revenue of $55.31 million for the quarter, compared to analyst estimates of $52.71 million. As a group, equities analysts anticipate that American Well will post -9.34 earnings per share for the current year.

Insider Transactions at American Well

In other American Well news, insider Dmitry Zamansky sold 6,243 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $4.85, for a total value of $30,278.55. Following the transaction, the insider directly owned 191,468 shares in the company, valued at $928,619.80. The trade was a 3.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders have sold 14,633 shares of company stock worth $67,972. 11.82% of the stock is owned by insiders.

Institutional Investors Weigh In On American Well

A number of large investors have recently added to or reduced their stakes in AMWL. Headlands Technologies LLC acquired a new position in shares of American Well during the second quarter valued at $39,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of American Well in the third quarter worth about $62,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of American Well during the 2nd quarter worth about $89,000. Engineers Gate Manager LP bought a new stake in shares of American Well during the second quarter valued at approximately $101,000. Finally, Prelude Capital Management LLC acquired a new position in shares of American Well in the 3rd quarter worth approximately $86,000. 56.05% of the stock is owned by institutional investors and hedge funds.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.